136 related articles for article (PubMed ID: 22048026)
1. Micro RNA -214,-150,-146a and-125b target Huntingtin gene.
Sinha M; Ghose J; Bhattarcharyya NP
RNA Biol; 2011; 8(6):1005-21. PubMed ID: 22048026
[TBL] [Abstract][Full Text] [Related]
2. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease.
Ghose J; Sinha M; Das E; Jana NR; Bhattacharyya NP
PLoS One; 2011; 6(8):e23837. PubMed ID: 21887328
[TBL] [Abstract][Full Text] [Related]
3. Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA.
Kim KH; Abu Elneel K; Shin JW; Keum JW; Seong D; Kwak S; Lee R; Gusella JF; MacDonald ME; Seong IS; Lee JM
J Hum Genet; 2019 Oct; 64(10):995-1004. PubMed ID: 31296921
[TBL] [Abstract][Full Text] [Related]
4. Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP.
Sinha M; Ghose J; Das E; Bhattarcharyya NP
Biochem Biophys Res Commun; 2010 Jun; 396(3):742-7. PubMed ID: 20451497
[TBL] [Abstract][Full Text] [Related]
5. Regulation of huntingtin gene expression by miRNA-137, -214, -148a, and their respective isomiRs.
Kozlowska E; Krzyzosiak WJ; Koscianska E
Int J Mol Sci; 2013 Aug; 14(8):16999-7016. PubMed ID: 23965969
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mitochondrial morphology and cell cycle by microRNA-214 targeting Mitofusin2.
Bucha S; Mukhopadhyay D; Bhattacharyya NP
Biochem Biophys Res Commun; 2015 Oct; 465(4):797-802. PubMed ID: 26307536
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms.
Jovicic A; Zaldivar Jolissaint JF; Moser R; Silva Santos Mde F; Luthi-Carter R
PLoS One; 2013; 8(1):e54222. PubMed ID: 23349832
[TBL] [Abstract][Full Text] [Related]
8. Heat Shock Factor 1-Regulated miRNAs Can Target Huntingtin and Suppress Aggregates of Mutant Huntingtin.
Das S; Bhattacharyya NP
Microrna; 2015; 4(3):185-93. PubMed ID: 26634350
[TBL] [Abstract][Full Text] [Related]
9. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
10. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.
Hu J; Liu J; Corey DR
Chem Biol; 2010 Nov; 17(11):1183-8. PubMed ID: 21095568
[TBL] [Abstract][Full Text] [Related]
11. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
[TBL] [Abstract][Full Text] [Related]
12. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
Bithell A; Johnson R; Buckley NJ
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
[TBL] [Abstract][Full Text] [Related]
14. microRNA-128a dysregulation in transgenic Huntington's disease monkeys.
Kocerha J; Xu Y; Prucha MS; Zhao D; Chan AW
Mol Brain; 2014 Jun; 7():46. PubMed ID: 24929669
[TBL] [Abstract][Full Text] [Related]
15. Development of a dual-luciferase reporter system for in vivo visualization of MicroRNA biogenesis and posttranscriptional regulation.
Lee JY; Kim S; Hwang DW; Jeong JM; Chung JK; Lee MC; Lee DS
J Nucl Med; 2008 Feb; 49(2):285-94. PubMed ID: 18199619
[TBL] [Abstract][Full Text] [Related]
16. High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo.
Huang B; Schiefer J; Sass C; Landwehrmeyer GB; Kosinski CM; Kochanek S
Hum Gene Ther; 2007 Apr; 18(4):303-11. PubMed ID: 17472569
[TBL] [Abstract][Full Text] [Related]
17. Altered microRNA regulation in Huntington's disease models.
Lee ST; Chu K; Im WS; Yoon HJ; Im JY; Park JE; Park KH; Jung KH; Lee SK; Kim M; Roh JK
Exp Neurol; 2011 Jan; 227(1):172-9. PubMed ID: 21035445
[TBL] [Abstract][Full Text] [Related]
18. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.
Kim YJ; Yi Y; Sapp E; Wang Y; Cuiffo B; Kegel KB; Qin ZH; Aronin N; DiFiglia M
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12784-9. PubMed ID: 11675509
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.
Soldati C; Bithell A; Johnston C; Wong KY; Stanton LW; Buckley NJ
J Neurochem; 2013 Feb; 124(3):418-30. PubMed ID: 23145961
[TBL] [Abstract][Full Text] [Related]
20. Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity.
Khoshnan A; Ko J; Watkin EE; Paige LA; Reinhart PH; Patterson PH
J Neurosci; 2004 Sep; 24(37):7999-8008. PubMed ID: 15371500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
